Levemir insulin, a long-acting insulin analog produced by Novo Nordisk, has a list price that can vary significantly. Without insurance or specific discount programs, the cost of a Levemir FlexTouch pen can range from approximately $300 to over $400 per 3-ml pen [1].
How does insurance affect Levemir's cost?
Insurance coverage plays a crucial role in the out-of-pocket cost for Levemir. Many insurance plans provide coverage for Levemir, but copay amounts differ based on the specific plan. Patients may find their costs reduced to a copay between $20 and $100 per pen, depending on their formulary and benefits [1].
Are there ways to get Levemir for less?
Novo Nordisk offers a savings card for eligible commercially insured patients, which can reduce the monthly cost for Levemir FlexTouch to as low as $0 for up to a 12-month period, subject to program terms and maximum savings limits [1]. Patients without insurance may also explore discount cards or patient assistance programs, though these vary in availability and benefit [1].
When does Levemir's patent protection end?
Information regarding the specific patent expiry dates for Levemir is available through resources like DrugPatentWatch.com [2]. These patents protect the drug from generic competition, influencing its pricing and market availability.
Who makes Levemir insulin?
Levemir insulin is manufactured by Novo Nordisk, a global healthcare company specializing in diabetes care [1].